Biotech · Private company
ReCode Therapeutics
Track this companyFree. Adds ReCode Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- IvacaftorPhase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- RCT2100Phase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- RCT1100Phase 1 · Primary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- RCT1100Phase 1 · Primary Ciliary Dyskinesia (PCD)ClinicalTrials.gov · fetched Nov 12, 2026
- CT of the chestPrimary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- MRI of the chestPrimary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- Mucociliary Clearance (MCC)Primary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- Multiple Breath Washout (MBW)Primary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- Sano Genetics Testing KitPrimary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
- SpirometryPrimary Ciliary DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary ClearancePHASE1 · COMPLETED · started Oct 22, 2024ClinicalTrials.gov NCT06633757 · fetched Nov 12, 2026
- A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 1, 2024ClinicalTrials.gov NCT06237335 · fetched Nov 12, 2026
- A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical TrialsACTIVE_NOT_RECRUITING · started Aug 31, 2023ClinicalTrials.gov NCT06172374 · fetched Nov 12, 2026
- A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in AdultsCOMPLETED · started Mar 8, 2023ClinicalTrials.gov NCT05685186 · fetched Nov 12, 2026
- Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD SubjectsPHASE1 · COMPLETED · started Feb 18, 2023ClinicalTrials.gov NCT05737485 · fetched Nov 12, 2026